VALIDATION IMAGES
Human liver cells lysates probed with CYP2E1 (1A26) Monoclonal Antibody (bsm-52923R) at 1:500 overnight at 4°C followed by a conjugated secondary antibody for 60 minutes at 37°C.
Paraformaldehyde-fixed and paraffin-embedded Human liver cancer tissue incubated with CYP2E1 (1A26) Monoclonal Antibody (bsm-52923R) at 1:100, overnight at 4°C, followed by a conjugated secondary antibody and DAB staining. Counterstained with hematoxylin.
Paraformaldehyde-fixed and paraffin-embedded Human liver tissue incubated with CYP2E1 (1A26) Monoclonal Antibody (bsm-52923R) at 1:100, overnight at 4°C, followed by a conjugated secondary antibody and DAB staining. Counterstained with hematoxylin.
Paraformaldehyde-fixed and paraffin-embedded Mouse liver tissue incubated with CYP2E1 (1A26) Monoclonal Antibody (bsm-52923R) at 1:100, overnight at 4°C, followed by a conjugated secondary antibody and DAB staining. Counterstained with hematoxylin.
IF(ICC) staining with CYP2E1 (1A26) Monoclonal Antibody (bsm-52923R) at 1:100 in Hela cells (red). The nuclear counterstain is DAPI (blue). Cells were fixed in paraformaldehyde, permeabilized with 0.25% Triton X100/PBS.
IF(ICC) staining with CYP2E1 (1A26) Monoclonal Antibody (bsm-52923R) at 1:100 in Hela cells (red). The nuclear counterstain is DAPI (blue). Cells were fixed in paraformaldehyde, permeabilized with 0.25% Triton X100/PBS.